Favorable mortality-to-incidence ratios of kidney Cancer are associated with advanced health care systems-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Favorable mortality-to-incidence ratios of kidney Cancer are associated with advanced health care systems

Published:2018-08-06 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Sung Wen-Wei,Wang Shao-Chuan,Hsieh Tzuo-Yi,Ho Cheng-Ju,Huang Cheng-Yu,Kao Yu-Lin,Chen Wen-Jung,Chen Sung-Lang

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-4698-6.pdf

Reference23 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.

2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.

3. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.

4. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.

5. Rathmell WK, Godley PA, Rini BI. Renal cell carcinoma. Curr Opin Oncol. 2005;17(3):261–7.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal Neoplasms with Concurrent Castleman-Like Regional Lymphadenopathy;International Journal of Surgical Pathology;2024-08-30

2. Targeting the Adenosine A2A Receptor as a Novel Therapeutic Approach for Renal Cell Carcinoma: Mechanisms and Clinical Trial Review;Pharmaceutics;2024-08-27

3. Burden of 30 cancers among men: Global statistics in 2022 and projections for 2050 using population‐based estimates;Cancer;2024-08-12

4. Construction of exosome-related genes risk model in kidney cell carcinoma predicts prognosis and immune therapy response;Aging;2024-05-07

5. Global epidemiology of kidney cancer;Nephrology Dialysis Transplantation;2024-02-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3